Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma

Management of the sensitized pediatric renal transplant candidate

Kidney transplantation is the treatment of choice for patients with ESRD as it is associated with improved patient survival and better quality of life, especially in children. There are several barriers to a successful transplant including organ shortage, anatomic barriers, and immunologic barriers. One of the biggest immunologic barriers that precludes transplantation is sensitization, when patients have antibodies prior to transplantation, resulting in positive crossmatches with donor. 30%-40% of adult patients on the wait list are sensitized. There is a growing number of pediatric patients on the wait list who are sensitized. This poses a unique challenge to the pediatric transplant community. Therefore, attempts to perform desensitization to remove or suppress pathogenic HLA antibodies resulting in acceptable crossmatches, and ultimately a successful transplant, while reducing the risk of acute rejection, are much needed in these children. This review article aims to address the management of such patients both prior to transplantation, with strategies to overcome sensitization, and after transplantation with monitoring for allograft rejection and other complications.

Coupling of multivariate curve resolution-alternating least squares and mechanistic hard models to investigate antibody purification from human plasma using ion exchange chromatography

A two steps proposal for the purification of immunoglobulin G from human blood plasma is investigated. The first step is precipitation using cold ethanol based on the Cohn method with some modification and the second step is a chromatographic separation by DEAE-Sepharose FF resin as a weak anion exchanger. The presence of interferent in the region3 of chromatographic fractions, which is co-eluted with IgG, restricts the application of the mechanistic chromatography model. Therefore, multivariate cure resolution-alternating least squares (MCR-ALS) as a soft method is employed on measured absorbance data matrix from eluted fractions to recover pure concentration and spectral profiles. Besides, possible solutions for resolved concentration and spectral profiles are investigated. The reaction-dispersive model as a mechanistic hard model for the column is utilized for the evaluation of the ion exchange chromatography. Using a genetic algorithm as a global optimization method, mobile phase modulator (MPM) adsorption model parameters such as β, k_des,0, and K_eq,0, were fitted to the concentration profiles from MCR-ALS as 1.96, 2.87×10^-4 m³ mol^-1s^-1, and 1883, respectively. Furthermore, a new resampling incorporated non-parametric statistics is conducted to assess parameters' uncertainty. Values of 2.00, 1.10×10^-3 m³ mol^-1s^-1, and 549.80 are estimated median, and values of 0.05, 2.5×10^-3, and 691.00 are calculated interquartile range (IQR) for β, k_des,0, and K_eq,0, respectively. Finally, results show three and two outliers for β and k_des,0, respectively.

Antibodies purification from human plasma using fractionation, chromatography and gel electrophoresis assisted by multivariate analysis of complimentary absorption and fluorescence spectra

Employing simple precipitation (fractionation) using Cohn method and weak anion exchange chromatography with DEAE resin, antibodies such as Immunoglobulin G are purified from human plasma. Fractions are eluted from column in four different regions depending on washing NaCl concentrations. Absorbance and excitation-emission fluorescence spectral data are measured for separated chromatographic fractions and analyzed using Multivariate Curve Resolution- Alternating Least Squares (MCR-ALS) and Parallel Factor Analysis (PARAFAC) techniques. Resolved concentration and spectral profiles provided information about existing components in each fraction. Protein and non-protein components are distinguished considering their resolved pure spectra and information from the two applied spectroscopic techniques is complementary. A number of components displayed both fluorescence and absorbance signals. When concentration of component (protein or non-protein) in sample is low and no significant absorbance signal is observed, sensitive fluorescence is useful to recognize the component and for non-fluorescent components absorbance spectra are utilized. Electrophoresis is utilized for separation of proteins in each fraction and showed that one distinguished protein from fluorescence and/or absorbance data can be a group of proteins with similar pure spectra and retention volume. Results showed presence of two protein in the first region (IgM and IgA), a group of proteins in second region (IgM, α-globulin, and IgG), a pure protein in third region (IgG), and a group of β-globulin proteins in fifth region. It is well and clearly shown that multivariate analysis of different data sets with complementary information is necessary for better interpretation of such technically simple and biochemically complicated systems.

The Protein/Peptide Direct Virus Inactivation During Chromatographic Process: Developing Approaches

Virus clearance is required for pharmaceutical preparations derived from animal or human sources such as blood products, vaccines, recombinant proteins produced in mammalian cell lines, etc. High cost and substantial protein losses during virus inactivation are significant problems for protein/peptide manufacturing. The goal of this project was to develop a method to perform virus inactivation in a course of protein chromatographic purification. Another goal was to show that the chromatographic adsorbent can serve as reliable "sieva" for mechanical washing away of infecting viruses. Using chromatographic, photometric, IFA, and RT-PCR approaches, it was discovered that high temperature-depending dynamic capacity of adsorbent allowed to perform a virus inactivation directly in a chromatographic column by solvent/detergent treatment. The peptide/protein biological activity was completely preserved. Using this new approach enveloped and nonenveloped viruses were effectively removed protein preparation. In addition, it was shown that RT-PCR method demonstrates more precise and reproducible results and robust properties for assessment of virus reduction than virus titer followed by infectivity studies. Presented method allowed to obtain the factor of virus concentration decrease (FVD) values that were higher than those provided by known technologies and was sufficient for a full inactivation of viruses. The method is recommended to use in pharmaceutical industry.

B-cell modulation of dendritic-cell function: signals from the far side

An appropriate immune response against a specific pathogen requires finely orchestrated interactions between the various cell populations within the immune system. At the same time, immunological tolerance to self must be maintained. DCs play an essential role in achieving these dual requisites. They coordinate adaptive immunity by integrating signals directly emanating from both infectious agents and cells of the immune system. Many such signals, especially those from innate cells and T cells, have been extensively characterized. In contrast, little is known about how B cells modulate function of DCs. B cells produce a variety of cytokines, including IL-10 and IL-6, which are known to influence DC function. In addition, Igs constitute the major secretory products of terminally differentiated B cells (plasma cells). DCs express various types of receptors for binding Ig, such as Fc receptors and C-type lectin receptors. In accordance, Igs can regulate DC function depending on the receptors engaged. Here, we review the emerging immunomodulatory role of cytokines and Ig secreted by B cells. We discuss the evidence for how these B-cell-derived factors may shape the adaptive immune response by directly acting on DCs.

Quality evaluation of human serum albumin prepared by heat denaturation in Iran: an experience for developing countries

Blood and plasma are unique resources and access to these products save life. In this study, albumin demand and surplus plasma makes it possible to use local experiences in plasma industry for preparation of albumin so plasma was heated after stabilization; afterward denatured proteins were precipitated and separated by continuous centrifuge system. The supernatant contained albumin was filtrated, diafiltrated, ultrafiltrated, formulated and pasteurized. Albumin preparation in pilot scale with heat denaturation was performed for the first time in Iran. This method using surplus plasma is recommended for all countries that have no access to plasma fractionation industry. Therefore with more attention it has potential for use in the production of safe plasma derived products and thereby it can be used as a safe product in clinic.